JohnSuttonWelchMD
Oncology • Saint Louis, MOAssociate Professor, Internal Medicine, Division of Oncology, Washington University in St. Louis School of Medicine
Dr. Welch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-454-8339Fax+1 314-454-5656
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2006 - 2010- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2006
University of California San Diego School of MedicineClass of 2004
Certifications & Licensure
MO State Medical License 2007 - 2025- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Elected Member ASCI, 2017
Clinical Trials
- Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Start of enrollment: 2014 Aug 11
- Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma Start of enrollment: 2014 Mar 19
- Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma Start of enrollment: 2014 Aug 20
- Join now to see all
Publications & Presentations
PubMed
- Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, Gue Su Chang, Sridhar Nonavinkere Srivatsan
Leukemia. 2024-10-04 - Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes.Agata Gruszczynska, Abhishek Maiti, Christopher A Miller, Sai Mukund Ramakrishnan, Daniel C Link
Haematologica. 2024-08-01 - 1 citationsTissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.Yohei Hisada, Tomohiro Kawano, Sierra J Archibald, John S Welch, Brandi N Reeves
Blood Advances. 2023-09-26
Journal Articles
- TP53 Immunohistochemistry Correlates TP53 Mutation Status and Clearance in Decitabine-Treated Patients with Myeloid MalignanciesJohn S Welch, Eric J Duncavage, Haematologica
- Exome Analysis of Treatment‐Related AML After APL Suggests Secondary EvolutionJohn S Welch, Eric J Duncavage, Meagan A Jacoby, Peter Westervelt, Lukas D Wartman, British Journal of Haematology
Abstracts/Posters
- Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Results of a Phase II TrialClinically Relevant AbstractJohn S. Welch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax RegimensJohn S. Welch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Whole Genome Bisulfite Sequencing of 63 Primary AML Samples Identifies a Unique DNA Hypermethylation Signature for Mutant IDH1/2 Cases That Is Different from That of T...John S. Welch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
Notable Launches New Clinical Study with Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity and ResistanceAugust 6th, 2020
$11.5 Million Supports Innovation in Leukemia ResearchNovember 6th, 2018- $11.5 Million Supports Innovation in Leukemia ResearchNovember 6th, 2018
- Join now to see all
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
